CANSWERIST®

Most recent stories in CANSWERIST®

• 

  socialcurrentsee® aka CANSWERIST®

  

  4 days ago

  Gamechanging new drug transforms how doctors treat brain tumors

  thebrighterside.news - JJ Shavit

  In a groundbreaking development, a leading cancer expert from UVA Health has brought attention to a new drug with the potential to significantly …

• 

  socialcurrentsee® aka CANSWERIST®

  

  After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials

  benzinga.com - Rachael Green

  Starpax Biopharma is preparing to start clinical trials this year with its patented Starpax cancer treatment platform across six unmet needs, …

• 

  socialcurrentsee® aka CANSWERIST®

  

  Blood cancer awareness: Common types, signs and treatment options

  Fox News - Ashlyn Messier

  Blood cancer affects the body's ability to fight against infection. For rapidly growing forms, it will need to be treated immediately, but slower growing forms are typically monitored, and treatment is not necessary right away. There are three main types of blood cancer, leukemia, lymphoma and …

• 

  socialcurrentsee® aka CANSWERIST®

  

  7 cancer-fighting foods to add to your diet

  Medical News Today - Jamie Eske

  People often talk about berries, fatty fish, walnuts, and other items as cancer-fighting foods. It means they contain nutrients that may lower the …

• 

  socialcurrentsee® aka CANSWERIST®

  

  Google and the Department of Defense are building an AI-powered microscope to help doctors spot cancer

  CNBC - Ashley Capoot

  In his office at the VA hospital in Seattle, Dr. Nadeem Zafar needed to settle a debate. Zafar is a pathologist, the kind of doctor that carries out …

• 

  socialcurrentsee® aka CANSWERIST®

  

  How Reed Jobs’ venture firm tackles cancer

  TechCrunch - Catherine Shu

  Reed Jobs’ new venture firm can change the lives of the estimated 18.1 million diagnosed cancer patients worldwide. Yosemite, Jobs’ fund for cancer-fighting biotech, launched in August with $200 million in funding from investors like MIT, Memorial Sloan Kettering Cancer Center and John Doerr. Jobs …